XML 25 R14.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2024

EARNINGS PER SHARE

EARNINGS PER SHARE

(8) EARNINGS PER SHARE

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Dilution resulting from stock-based compensation plans is determined using the treasury stock method and dilution resulting from the 2023 Convertible Senior Notes is determined using the if-converted method. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential common shares outstanding would be anti-dilutive.

The calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2024 and 2023 are as follows (in thousands, except per share data):


		For the Three Months Ended September 30,						For the Nine Months Ended September 30,
		2024			2023			2024			2023
Basic earnings per share
Net income		$	2,382		$	3,594		$	3,609		$	8,517
Basic weighted average shares outstanding			31,775			35,531			31,960			36,216

Basic earnings per share		$	0.07		$	0.10		$	0.11		$	0.24

Diluted earnings per share
Net income		$	2,382		$	3,594		$	3,609		$	8,517
Weighted average shares outstanding			31,775			35,531			31,960			36,216
Effect of dilutive securities - options and restricted stock			313			572			380			650
Diluted weighted-average shares outstanding			32,088			36,103			32,340			36,866

Diluted earnings per share		$	0.07		$	0.10		$	0.11		$	0.23

For the three and nine months ended September 30, 2024, equity grants of 54,000 and 13,000 shares of common stock, respectively, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive.

For the three and nine months ended September 30, 2023, equity grants of 92,000 and 34,000 shares of common stock, respectively, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive.

For both the three and nine months ended September 30, 2024, conversion options to purchase 5.6 million shares resulting from the 2023 Convertible Senior Notes, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive. For three and nine months ended September 30, 2023, conversion options to purchase 5.6 million and 3.0 million shares, respectively, resulting from the 2023 Convertible Senior Notes, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive (see Note 9 – Convertible Senior Notes).